In this regard, the herein demonstration that changes in the phenotypic and functional characteristics of normal ADSC upon treatment with SSc serum and recombinant TGFβ are comparable further supports that the peculiar SSc pathologic environment may direct the differentiation of ADSC toward a profibrotic fate. Here, TGFB1 is linked to systemic sclerosis.